2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension.
about
Hypertension in Chronic GlomerulonephritisStrategies for Controlling Blood Pressure and Reducing Cardiovascular Disease Risk in Patients with Chronic Kidney DiseaseArterial structure and function in inflammatory bowel diseaseAn update on renal artery denervation and its clinical impact on hypertensive diseaseWhat is the evidence base for diagnosing hypertension and for subsequent blood pressure treatment targets in the prevention of cardiovascular disease?Hypertension criterion for stroke prevention--to strengthen the principle of individualization in guidelinesSodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Cardiovascular Disease: A Systematic ReviewCurrent and Future Treatment of Hypertension in the SPRINT EraA Cross-Sectional Study of the Cardiovascular Effects of Welding FumesBeta-blockers for hypertension.Early Detection System of Vascular Disease and Its Application ProspectNew horizons: the management of hypertension in people with dementia.Treatment efficacy of anti-hypertensive drugs in monotherapy or combination: ATOM systematic review and meta-analysis of randomized clinical trials according to PRISMA statement.Common carotid intima-media thickness measurements do not improve cardiovascular risk prediction in individuals with elevated blood pressure: the USE-IMT collaboration.Autonomic dysfunction in mild cognitive impairment: evidence from power spectral analysis of heart rate variability in a cross-sectional case-control study.A method for calculating adherence to polypharmacy from dispensing data records.LEADER-4: blood pressure control in patients with type 2 diabetes and high cardiovascular risk: baseline data from the LEADER randomized trial.Telemonitoring and Protocolized Case Management for Hypertensive Community-Dwelling Seniors With Diabetes: Protocol of the TECHNOMED Randomized Controlled Trial.Variation in GP decisions on antihypertensive treatment in oldest-old and frail individuals across 29 countriesEfficacy of olmesartan amlodipine in Colombian hypertensive patients (soat study)Evolution of blood pressure in children with congenital and acquired solitary functioning kidney.Therapeutic Effects of Breviscapine in Cardiovascular Diseases: A ReviewThe 2017 Focused Update of the Guidelines of the Taiwan Society of Cardiology (TSOC) and the Taiwan Hypertension Society (THS) for the Management of HypertensionDiet quality and carotid atherosclerosis in intermediate cardiovascular risk individuals.In women with previous pregnancy hypertension, levels of cardiovascular risk biomarkers may be modulated by haptoglobin polymorphism.The effectiveness of daily SMS reminders in pharmaceutical care of older adults on improving patients' adherence to antihypertensive medication (SPPA): study protocol for a randomized controlled trialEfficacy and safety of valsartan/amlodipine single-pill combination in 11,422 Chinese patients with hypertension: an observational study.2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by represEffect of chlorthalidone, amlodipine, and lisinopril on visit-to-visit variability of blood pressure: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.How simple are 'simple renal cysts'?African Americans, hypertension and the renin angiotensin systemNon-interventional management of resistant hypertension.Immune activation, immunosenescence, and osteoprotegerin as markers of endothelial dysfunction in subclinical HIV-associated atherosclerosis.Endurance and Strength Athlete's Heart: Analysis of Myocardial Deformation by Speckle Tracking Echocardiography.Comparison of cardiovascular risk factors in different areas of health care over a 20-year period.24-hour central blood pressure and intermediate cardiovascular phenotypes in untreated subjects.The pathophysiology of hypertension in patients with obesity.Evaluation of 24-Hour Arterial Stiffness Indices and Central Hemodynamics in Healthy Normotensive Subjects versus Treated or Untreated Hypertensive Patients: A Feasibility StudyRed cell distribution width and inappropriateness of left ventricular mass in patients with untreated essential hypertension.Cardiovascular risk factor distribution and subjective risk estimation in urban women--the BEFRI study: a randomized cross-sectional study.
P2860
Q26768702-857AC7F3-D15E-4FA9-B82F-CFAC8627ACECQ26775393-E5DF96EC-F322-4A9F-AE86-5478346724F3Q26777549-CABF84B0-F731-4F93-A2C2-9ACD7C784B6AQ26780078-2B20944B-BD5F-4908-B8ED-8912ECD910E4Q26784487-51EACCD9-9440-4D26-AC45-4CD7882E55DEQ26992100-B67DCF0F-4E83-40FD-937C-CBE62C283A52Q28072352-8BA330FF-D697-4346-9B74-820E2E7D2CCBQ28073270-8F52F791-8E3E-446D-9C72-CD9567200D31Q28397849-E845B4F9-62F5-465D-AA82-D3F738521A52Q30238911-3B87D9B1-ECFC-4205-B87A-0E6946BB2846Q30239836-73AFA19E-1373-42D2-B1EB-579CD3D4EF1BQ30241411-C4C1BDEB-E770-46A3-BE4A-6B466B2702E6Q30248727-232B7A95-8B17-4F19-9707-773123A2CD88Q30371516-2950C6FA-5108-4C55-92A6-76B2C1580988Q30438683-F1FC73FA-EA58-4170-A998-A3E725A6551DQ30705053-B34250BA-1BA5-4738-9128-17033B10690EQ31043538-DA0AF78D-DC18-4365-917C-81424093A3BFQ33167337-0F79D4AC-8756-458C-8557-C07739605412Q33587218-FE5C63B5-DF02-4264-B1A8-32FA736A4112Q33604498-E971D6C2-FE22-44E6-8F16-E59A804E15A1Q33612811-53750E0F-305D-4780-A54F-0BCA396800B6Q33718458-F6AA7794-854B-4DC9-9023-483C9FC42758Q33729817-65C0C683-3C25-4EBD-B3B5-7E2755CC1F84Q33864219-83036369-5417-4AFE-9A14-25FED152990DQ33914919-C82C0FBD-7715-4EB7-AAB4-44AD6A2DE34CQ33916917-88C21982-6C2F-4CE1-88E8-104A35FD7B71Q33970085-AB11EB65-25B4-4216-B5FB-F9DF04CEC0B7Q34046881-756911C8-252C-427A-9247-F15A967302E9Q34078174-1364CD63-BB14-490A-8E09-E433907F8057Q34152248-2ED16ABE-EA2E-4E2C-AC1A-65BFA412EC9EQ34251854-6B78580A-7310-461B-97AC-F32C04178626Q34404475-9FD869D5-2ABF-42AC-877B-C0D21BD74064Q34412603-738BD738-E813-4573-969F-49A1D9F6379DQ34863538-F77B9729-32B5-48A7-819B-F1CEA3F7524DQ34914575-10133F3E-CCE2-49B7-9641-A8381C3B9891Q34987397-F85238FF-4590-45F1-8A7A-0A0CEAAE5DADQ35021492-2D487BBF-546C-4B50-970F-FA8E0E9B576CQ35064321-D237542F-A6BC-4844-A2F8-24D6FAF6782EQ35203105-4210259A-6152-4D39-BAA3-965033CEB600Q35215536-4ECC678C-CF9C-4791-ABD7-571A03EFEC4B
P2860
2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
2013 Practice guidelines for t ...... ment of Arterial Hypertension.
@ast
2013 Practice guidelines for t ...... ment of Arterial Hypertension.
@en
2013 Practice guidelines for t ...... ropean Society of Hypertension
@nl
type
label
2013 Practice guidelines for t ...... ment of Arterial Hypertension.
@ast
2013 Practice guidelines for t ...... ment of Arterial Hypertension.
@en
2013 Practice guidelines for t ...... ropean Society of Hypertension
@nl
prefLabel
2013 Practice guidelines for t ...... ment of Arterial Hypertension.
@ast
2013 Practice guidelines for t ...... ment of Arterial Hypertension.
@en
2013 Practice guidelines for t ...... ropean Society of Hypertension
@nl
P1476
2013 Practice guidelines for t ...... ment of Arterial Hypertension.
@en
P2093
ESH/ESC Task Force for the Management of Arterial Hypertension
P304
P356
10.1097/HJH.0B013E328364CA4C
P577
2013-10-01T00:00:00Z